Semaglutide linked to increased risk of severe eye condition NAION in new study

FHS
July 9, 2024
3:05 am

Research shows semaglutide users face a significantly higher risk of developing non-arteritic anterior ischemic optic neuropathy (NAION) compared to users of other medications for diabetes and obesity.

FDA seeks feedback on expansion of premarket cybersecurity guidance

Dive Brief: The Food and Drug Administration has requested feedback on plans to add a new section to the premarket cybersecurity guidance finalized last year. Through

March 13, 2024

Preterm babies show diverse cognitive and behavioral patterns

About thirteen million babies each year are born prematurely, with preterm birth linked to increases in risk for attention-deficit/hyperactivity disorder (ADHD), problems with social development,

August 14, 2024

Urban configuration impacts health and sustainability in Europe

The relationship between different urban layouts, human health, and sustainability.

July 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.